Pharmaceuticals & Drugs
|Market Cap||72,634 Cr||EPS||142.7||High||4394.9|
|Stock P/E||30.6||Net Profit Margin||17.4||Low||4357.1|
|Market Cap||72,634 Cr||ROE||26.6%|
|P/B Ratio||3.8||Dividend Yield||0.7%|
|Industry P/E||64.4||Book Value||1.2K|
Dr. Reddy’s Laboratories Limited commenced its generics business in India in 1986 and is today a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas. The company’s shares trade on the Bombay Stock Exchange and the National Stock Exchange in India and on the New York Stock Exchange in the United States.
Business area of the company
The company is a leading India-based pharmaceutical company headquartered and having its registered office in Hyderabad, Telangana, India. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations.
Pharmaceutical services & active ingredients
Awards & Recognitions
|Parent Organisation||Dr. Reddy's Laboratories Ltd.||Managing Director||GV Prasad|
All values are in Rs Cr
|Company||52 Week||Market Price||P/E Ratio|